Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

No cure for female pattern hair loss, but various effective treatments exist.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.